Investment Rating - The report maintains a "B" rating for the new materials sector, indicating a leading performance compared to the market [1]. Core Insights - The new materials sector has shown resilience, with the new materials index rising by 0.86%, outperforming the ChiNext index by 2.54% during the week [3]. - The vitamin sector is experiencing a price surge due to geopolitical tensions in the Middle East, particularly affecting the Hormuz Strait, which has led to increased costs across the petrochemical supply chain [5]. - Key vitamin products such as Vitamin A and E have seen significant price increases, with Vitamin A reaching 110,000 CNY/ton (up 15.79% week-on-week) and Vitamin E at 101,000 CNY/ton (up 18.82% week-on-week) [5]. Summary by Sections Market Performance - The new materials sector has outperformed the broader market indices, with specific segments like battery chemicals rising by 10.69% and industrial gases by 1.78% [3][12]. - Over the past five trading days, the synthetic biology index fell by 0.92%, while semiconductor materials dropped by 2.80% [3][16]. Price Tracking - Amino acids have shown stable prices, with valine at 14,550 CNY/ton and arginine at 23,250 CNY/ton [4]. - The price of Vitamin A has increased significantly, reflecting a broader trend of rising prices in the vitamin sector due to supply constraints [4][5]. Investment Recommendations - The report suggests focusing on companies within the vitamin supply chain, such as New Hope Liuhe, Andis, Meihua Biological, and Zhejiang Medicine, as they are expected to benefit from the ongoing price increases [5][6].

Investment Rating - The report maintains a "B" rating for the new materials sector, indicating a leading performance compared to the market [1]. Core Insights - The new materials sector has shown resilience, with the new materials index rising by 0.86%, outperforming the ChiNext index by 2.54% during the week [3]. - The vitamin sector is experiencing a price surge due to geopolitical tensions in the Middle East, particularly affecting the Hormuz Strait, which has led to increased costs across the petrochemical supply chain [5]. - Key vitamin products such as Vitamin A and E have seen significant price increases, with Vitamin A reaching 110,000 CNY/ton (up 15.79% week-on-week) and Vitamin E at 101,000 CNY/ton (up 18.82% week-on-week) [5]. Summary by Sections Market Performance - The new materials sector has outperformed the broader market indices, with specific segments like battery chemicals rising by 10.69% and industrial gases by 1.78% [3][12]. - Over the past five trading days, the synthetic biology index fell by 0.92%, while semiconductor materials dropped by 2.80% [3][16]. Price Tracking - Amino acids have shown stable prices, with valine at 14,550 CNY/ton and arginine at 23,250 CNY/ton [4]. - The price of Vitamin A has increased significantly, reflecting a broader trend of rising prices in the vitamin sector due to supply constraints [4][5]. Investment Recommendations - The report suggests focusing on companies within the vitamin supply chain, such as New Hope Liuhe, Andisoo, Meihua Biological, and Zhejiang Medicine, as they are expected to benefit from the ongoing price increases [5][6].

Investment Rating - The report does not explicitly provide an investment rating for the chemical industry Core Insights - The geopolitical tensions, particularly between the US and Iran, have led to significant disruptions in the chemical supply chain, affecting various sectors including fertilizers and semiconductors [1][2] - The chemical market is experiencing price fluctuations due to supply chain vulnerabilities, with specific products like helium and fertilizers facing acute shortages [1][2] - The AI industry is facing challenges due to increased demand for computing power, leading to a surge in CPU prices and extended delivery times [1] - Major companies are actively expanding production capacities to meet rising demand, with significant investments in AI infrastructure [1] Summary by Sections Market Review - Brent crude oil settled at an average of 105.45 USD/barrel, down 0.87% week-on-week, while WTI crude oil averaged 92.98 USD/barrel, down 3.22% [9] - The basic chemical sector outperformed the index with a 2.31% increase, while the petrochemical sector saw a slight decline of 0.10% [10] Recent Views from the Chemical Team - The tire industry is stabilizing with a slight increase in production rates, while raw material prices are on the rise [23] - The dye market remains stable, with prices for disperse dyes holding steady and active dyes experiencing an upward trend due to strong cost support [25] - The carbon dioxide market is seeing limited price increases due to insufficient demand support [27] Key Events - Iran's response to the US ceasefire proposal has introduced new conditions, impacting market stability [2] - Australia's largest ammonia plant has been offline for two months, exacerbating global fertilizer shortages during the planting season [2] - A significant reduction in helium supply from Qatar due to Iranian attacks poses a threat to the semiconductor industry [2]

Industry Investment Rating - The investment rating for the pharmaceutical and biotechnology industry is "Outperform" [1] Core Insights - The vitamin industry has entered a new price increase cycle, with significant price rises for several core products from historical lows. As of March 20, 2026, the price of Vitamin E (VE) increased from 55.5 CNY/kg to 85.0 CNY/kg, a rise of 53.15%; Vitamin A (VA) rose from 63.0 CNY/kg to 95.0 CNY/kg, an increase of 50.79%; Vitamin B3 (VB3) and calcium pantothenate also saw increases of 40.58% and 13.50% respectively. This price increase is supported by supply constraints and rising raw material costs due to geopolitical factors [4][6][13]. Summary by Sections 1. High Concentration of Vitamin Supply and Rigid Demand - The demand for vitamins, particularly from the feed sector, is rigid and insensitive to price changes, as vitamins are considered essential and irreplaceable additives in feed. The cost of vitamins in feed is very low, accounting for only 0.51% in egg-laying hen feed and 0.15% in fattening pig feed, which allows for greater price elasticity [5][20][21]. - The supply of core vitamin products is highly concentrated among a few leading companies, which possess strong pricing power. For instance, the top three companies in the Vitamin A (VA) market control over 50% of the capacity, while calcium pantothenate production is dominated by a few firms with over 70% market share [5][24][23]. 2. Synthesis Pathways: Dominated by Chemical Synthesis - Vitamin E is primarily produced through chemical synthesis, with key intermediates being isophytol and 2,3,5-trimethylhydroquinone. The production process faces challenges related to the supply and price volatility of these intermediates [29][31]. - Vitamin A synthesis involves multiple pathways, with citral being a core intermediate. The production methods are complex and closely tied to the availability and pricing of citral, which has historically influenced Vitamin A prices [34][39]. 3. Historical Price Review: Supply Constraints as Core Drivers - Historical analysis shows that price increases in vitamins are primarily driven by supply constraints, often due to unexpected events such as factory accidents or environmental inspections. The high concentration of the industry amplifies price elasticity, allowing leading companies to exert significant pricing power [44][46]. - The demand for vitamins remains robust even during price increases, as customers tend to stock up in anticipation of further price hikes, demonstrating the significant price elasticity of vitamins [44][45].

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [1][7]. Core Viewpoints - The price of methionine and vitamin E has increased significantly, with methionine prices rising by 84.66% and vitamin E by 40.54% since the beginning of the year [2]. - The global methionine production capacity is approximately 2.7 million tons per year, with 44% of this capacity facing challenges outside of China and the US, particularly in Europe and Asia [2][3]. - The rising costs of raw materials and energy, including a 29% increase in Brent crude oil prices and a 56% increase in Dutch TTF natural gas prices, are expected to continue affecting production costs [3][8]. - The methionine and vitamin E industries are characterized by oligopolistic market structures, allowing major companies to exert pricing power [3][9]. - New Hope Liuhe, as the third-largest methionine producer and the largest vitamin E producer globally, is well-positioned to benefit from the price increases in these products [4][19]. Summary by Relevant Sections Methionine Market - The demand for methionine is expected to grow at a compound annual growth rate (CAGR) of 5.21% from 2014 to 2024, increasing from 1.023 million tons to 1.7 million tons [5]. - The production capacity distribution shows that China accounts for approximately 40% of global methionine capacity, while Europe and Asia (excluding China) account for over 40% combined [6]. Vitamin E Market - The global vitamin E market is highly concentrated, with only six major producers controlling 92% of the market [16]. - The price of vitamin E has also seen a significant increase, with a 40.54% rise since the beginning of the year [18]. Financial Projections - The company is expected to achieve net profits of 6.792 billion yuan in 2025, 7.248 billion yuan in 2026, and 7.737 billion yuan in 2027, with corresponding price-to-earnings ratios of 17.8, 16.7, and 15.6 [19][23].

Summary of the Conference Call on Vitamin Industry Industry Overview - The calcium pantothenate industry is experiencing severe overcapacity, with global production capacity at 50,000-60,000 tons compared to a demand of 23,000-25,000 tons. Major producers Newfa and Yifan have a combined capacity of 22,000 tons, sufficient to meet global demand [2][3] - The supply chain is heavily concentrated in China, with over 80% of global capacity located there [3] Key Points on Pricing and Market Dynamics - Calcium pantothenate prices fell to a historical low of 35 CNY/kg, driven by a 50% increase in raw material costs due to geopolitical tensions. Manufacturers have stopped quoting prices, leading to speculation of a price rebound [2][4][5] - The price recovery ceiling is estimated at 100 CNY/kg, constrained by the weak financial state of the downstream livestock industry, which is currently facing significant losses [2][4][7] - The recovery threshold for second and third-tier manufacturers to resume production is projected to be between 65-70 CNY/kg, as many small producers are currently unprofitable [2][7] Supply and Demand Insights - The global demand for calcium pantothenate is expected to reach approximately 23,000 tons by 2025, with major foreign producers like BASF and DSM contributing around 4,000-5,000 tons [3] - The top domestic producers, Newfa and Yifan, have capacities of 12,000 tons and 10,000 tons, respectively, with additional capacities under construction [3] Historical Context and Future Projections - Historical price surges have been linked to supply disruptions, such as safety incidents and environmental regulations. The current price increase is primarily driven by rising raw material costs and market speculation [6][10] - The market is currently in a state of negotiation between manufacturers and distributors, with a significant focus on the livestock industry's ability to absorb price increases [8][9][12] Other Vitamins Market Dynamics - Vitamin E and A are also under pressure, with Vitamin E's global capacity at 150,000 tons against a demand of 90,000 tons. The entry of new capacities from Wanhua Chemical is expected to impact the market significantly [2][14] - The price of Vitamin A has recently increased from 57 CNY/kg to over 75 CNY/kg due to supply constraints and market speculation [16] Conclusion - The calcium pantothenate market is characterized by overcapacity and fluctuating prices influenced by raw material costs and the financial health of the livestock sector. The interplay between supply and demand, along with geopolitical factors, will continue to shape the market dynamics in the near future [2][10][12]

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [1][7]. Core Viewpoints - The price of methionine and vitamin E has increased significantly, with methionine prices rising by 84.66% and vitamin E by 40.54% since the beginning of the year [2]. - The global methionine production capacity is approximately 2.7 million tons per year, with 44% of the capacity outside of China and the US facing challenges due to rising raw material prices and shortages [2][3]. - Major producers of methionine and vitamin E are experiencing production challenges due to high energy and raw material costs, particularly in Europe and Asia [3][4]. - The oligopolistic nature of the methionine and vitamin E industries allows leading companies to maintain pricing power, with strong demand from downstream applications [3][4]. - The company is positioned to benefit from the rising prices of methionine and vitamin E, being the third-largest producer of methionine and the largest producer of vitamin E globally [4]. Summary by Sections Market Conditions - As of March 12, the market prices for methionine and vitamin E are 32.5 and 78 RMB per kilogram, respectively, reflecting significant increases from earlier in the year [2]. - The production capacity of methionine is concentrated, with the top three companies accounting for about 71% of the market [9]. Cost Structure - The production costs for methionine have risen sharply due to increases in the prices of key raw materials such as natural gas, methanol, and sulfur [3][8]. - The cost of methionine in poultry feed is relatively low, allowing producers to pass on cost increases to downstream customers effectively [10]. Financial Projections - The company is expected to see a significant increase in net profit, with projections of 67.92 billion RMB for 2025 and 72.48 billion RMB for 2026, corresponding to a price-to-earnings ratio of 17.8 and 16.7, respectively [19].

Investment Rating - The report maintains a "stronger than market" rating for the chemical sector [5]. Core Insights - The merger between AkzoNobel and Sherwin-Williams is expected to create a leading global paint company with annual revenues of $17 billion (approximately 120.9 billion RMB) [3]. - The Ministry of Commerce continues to impose anti-dumping duties on imported propanol from the U.S., with rates ranging from 254.4% to 267.4% [3]. - The domestic tire industry shows strong competitiveness, with scarce growth targets worth attention, including Sailun Tire, Senqilin, General Shares, and Linglong Tire [4]. - The consumer electronics sector is anticipated to gradually recover, benefiting upstream material companies, with recommendations to focus on companies like Dongcai Technology and Stik [4]. - The phosphorous chemical sector is highlighted for its resilience due to supply constraints and increasing demand from the new energy sector, with suggested companies including Yuntianhua and Chuanheng Shares [4]. - The report emphasizes the importance of leading companies in the chemical industry benefiting from economic recovery and demand resurgence, recommending companies like Wanhua Chemical and Hualu Hengsheng [4]. Summary by Sections Market Performance - The Shanghai Composite Index fell by 3.9%, the ChiNext Index by 6.15%, and the CSI 300 by 3.77%, while the CITIC Basic Chemical Index dropped by 8.24% [14]. - The top five performing sub-industries in the chemical sector were rubber additives (1.75%), potassium fertilizer (-1.21%), tires (-2.84%), modified plastics (-4.32%), and membrane materials (-5.19%) [17]. Major Industry Dynamics - The merger between AkzoNobel and Sherwin-Williams is set to create a company with a business scope covering various paint solutions and an expected annual revenue of $17 billion [3]. - The Ministry of Commerce's anti-dumping measures on U.S. propanol will continue, affecting pricing and supply dynamics in the market [3]. Investment Themes - The tire sector is highlighted for its competitive domestic enterprises, with specific companies recommended for investment [4]. - The consumer electronics sector is expected to recover, with upstream material companies poised to benefit [4]. - The phosphorous chemical sector is noted for its tightening supply-demand balance, with several companies recommended for attention [4]. - The report suggests focusing on leading companies in the chemical industry that are likely to benefit from economic recovery and demand resurgence [4].

Investment Rating - The report rates the chemical industry as "Outperforming the Market" [2] Core Views - The report highlights the decline in international oil prices and methionine prices, while prices for VA and VE have increased. It suggests focusing on sectors mentioned in the "14th Five-Year Plan," undervalued leading companies, the impact of "anti-involution" on supply, and electronic materials companies under the context of self-sufficiency [2][3][10] Summary by Sections Industry Dynamics - In the week of October 27 to November 2, among 100 tracked chemical products, 29 saw price increases, 39 saw declines, and 32 remained stable. 28% of products had month-on-month price increases, while 57% saw declines [10][34] - The average price of sulfuric acid, vitamin E, nitric acid, sulfur, and hydrochloric acid increased, while the prices of raw salt, acetic acid, coal tar, and methanol decreased [10][34] - International oil prices fell, with WTI crude oil futures closing at $60.98 per barrel, down 0.85%, and Brent crude at $65.07 per barrel, down 1.32% [10][35] Price Trends - Vitamin A prices rose to 62 CNY/kg, up 1.64% week-on-week, while vitamin E prices increased to 50 CNY/kg, up 8.70% week-on-week. Both products are experiencing tight supply conditions [36] - Methionine prices decreased to 20.3 CNY/kg, down 1.46% week-on-week, with production increasing to 16,600 tons [37] Investment Recommendations - As of October 31, the TTM P/E ratio for the basic chemical sector is 24.39, at the 72.21% historical percentile, while the P/B ratio is 2.21, at the 53.61% historical percentile. The oil and petrochemical sector has a TTM P/E of 12.40, at the 31.95% historical percentile [13] - The report recommends focusing on sectors supported by policies, undervalued leading companies, and sectors with potential for high demand recovery, such as fluorochemicals, agricultural chemicals, refining, dyes, polyester filament, and tires [13][10] - Specific stock recommendations include Wanhua Chemical, Hualu Hengsheng, Satellite Chemical, and others, with a focus on companies like Yangnong Chemical and Tongcheng New Materials [10][13]

Investment Rating - The report maintains a "Buy" rating for Wanhua Chemical [1][7][17] Core Views - The company's Q2 performance shows signs of stabilization, with expectations for a cyclical recovery in the industry [5][11] - In H1 2025, the company achieved total revenue of 90.901 billion yuan, a year-on-year decrease of 6.35%, and a net profit attributable to shareholders of 6.123 billion yuan, down 25.10% year-on-year [4][5] - The polyurethane sector is expected to improve profitability due to rising TDI and MDI prices, while the petrochemical segment faces challenges from oversupply [5][6] Summary by Sections Financial Performance - In Q2 2025, the company reported revenue of 47.833 billion yuan, an 11% increase quarter-on-quarter, with net profit of 3.04 billion yuan remaining stable [5] - The company’s second ethylene unit with a capacity of 1.2 million tons/year has successfully commenced operations [6] Business Segments - The polyurethane industry shows stable demand, particularly in the new energy and high-end manufacturing sectors, driven by the lightweight requirements of electric vehicles [5] - The fine chemicals and new materials segments are experiencing steady growth, with ongoing product and capacity releases contributing to revenue stability [5][6] Future Outlook - The company is expected to see EPS of 4.3, 5.34, and 6.29 yuan for 2025, 2026, and 2027 respectively, indicating a positive growth trajectory [7][8] - The report anticipates a revenue growth rate of 10.91% in 2025, with further increases in subsequent years [8][13]